Artemis Medicare Services Ltd Reports Robust Q1 FY26 Results with 28.2% Growth in Net Profit

Gurugram:  Artemis Medicare Services Ltd. has announced robust performance for Q1 for financial year 2025–26, with a consolidated gross revenue of ₹2,681 million for Q1, an upturn of 14.4% year on year. The Board of Directors were pleased to have approved the financial results for the quarter ended June 30, 2025, showing steady performance on all metrics.

The company’s net revenue from operations went up by 14.2% to ₹2,550 million from ₹2,232 million in the first quarter of FY25. The company’s EBITDA went up 19.0% to ₹483 million, with a good margin of 19.0%. Most importantly, net profit jumped 28.2% to ₹212 million, up from ₹165 million in the same quarter last year.

Artemis Hospital in Gurgaon also delivered impressive results. The hospital’s net income went up 16.0% to ₹2,412 million. The average revenue per occupied bed (ARPOB) went up to ₹83,900, the highest it has ever been. In Q1 FY25, it was ₹79,200. EBITDA for the hospital went up to ₹495 million, keeping a margin of 20.5%. Overseas sales were a big part of this, going up by 31.4% to ₹704 million, which is 29% of net sales. The average length of stay (ALOS) was 3.7 days, and 61.2% of the beds were full.

Commenting about the performance, Mr. Onkar Kanwar, Chairman, Artemis Medicare Services Ltd. remarked, “We are glad to share our strong beginning to FY26, where Q1 has shown consistent growth and strong operational performance notwithstanding being a seasonally soft quarter. Our efforts on cost optimization, operational efficiency, and international patients have further strengthened our leadership position in Medical Value Travel.”

Significant achievements were the new beds built in the third tower of the flagship hospital, a binding MoU with Dr. Vidya Sagar Kaushalya Devi Memorial Health Centre, to develop the north of India, and, the launch of India’s first private Geriatrics & Longevity Department. Artemis also formed a partnership with KIMS, Hyderabad, to conduct heart-lung transplants, as part of its operational model, which is high quality care, and safe, highly funded medical care. Artemis has and is committed to continue this momentum through progressive partnerships, clinical innovation, and geographic expansion.